Persistence of AAV Vector Genomes in Dystrophic Muscle
Author Information
Author(s): Christina A. Pacak, Thomas J. Conlon, Cathryn S. Mah, Barry J. Byrne
Primary Institution: University of Florida
Hypothesis
The therapeutic vector would establish long-term persistence through prevention of myofiber turnover.
Conclusion
The therapeutic vector maintained vector genome persistence in skeletal muscle better than the reporter vector.
Supporting Evidence
- The therapeutic vector led to prolonged vector genome persistence in skeletal muscle.
- Loss of vector genomes was observed in muscles not protected by therapeutic gene transfer.
- The study suggests that fast-twitch muscle fibers may turnover more rapidly than slow-twitch fibers.
Takeaway
This study shows that a special virus can help muscles stay healthy longer in mice with a muscle disease.
Methodology
Mice were injected with two types of vectors in their hindlimbs, and muscle samples were analyzed for vector genome persistence at 4 and 12 months post-injection.
Potential Biases
Potential bias in the assessment of muscle fiber turnover due to uneven vector distribution.
Limitations
The delivery method may not distribute the vector evenly across all muscle fibers.
Participant Demographics
One-day-old alpha sarcoglycan knockout mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website